Elsevier

Gastrointestinal Endoscopy

Volume 90, Issue 5, November 2019, Pages 793-804
Gastrointestinal Endoscopy

Original article
Clinical endoscopy
Independent root-cause analysis of contributing factors, including dismantling of 2 duodenoscopes, to investigate an outbreak of multidrug-resistant Klebsiella pneumoniae

https://doi.org/10.1016/j.gie.2019.05.016Get rights and content

Background and Aims

Worldwide, an increasing number of duodenoscope-associated outbreaks are reported. The high prevalence rate of contaminated duodenoscopes puts patients undergoing ERCP at risk of exogenous transmission of microorganisms. The contributing factors of the duodenoscope design to contamination are not well understood. This article reports on the investigation after the outbreak of a multidrug-resistant Klebsiella pneumoniae (MRKP) related to 2 Olympus TJF-Q180V duodenoscopes.

Methods

We conducted a contact patient screening and microbiologic laboratory database search. Reprocessing procedures were audited, and both duodenoscopes were fully dismantled to evaluate all potential contamination factors. Outcomes were reviewed by an experienced independent expert.

Results

In total, 102 patients who had undergone an ERCP procedure from January to August 2015 were invited for screening. Cultures were available of 81 patients, yielding 27 MRKP-infected or -colonized patients. Ten patients developed an MRKP-related active infection. The 2 duodenoscopes had attack rates (the number of infected or colonized cases/number of exposed persons) of 35% (17/49) and 29% (7/24), respectively. Identical MRKP isolates were cultured from channel flushes of both duodenoscopes. The review revealed 4 major abnormalities: miscommunication about reprocessing, undetected damaged parts, inadequate repair of duodenoscope damage, and duodenoscope design abnormalities, including the forceps elevator, elevator lever, and instrumentation port sealing.

Conclusions

Outbreaks are associated with a combination of factors, including duodenoscope design issues, repair issues, improper cleaning, and systemic monitoring of contamination. To eliminate future duodenoscope-associated infections, a multipronged approach is required, including clear communication by all parties involved, a reliable servicing market, stringent surveillance measures, and eventually new duodenoscope designs and reprocessing procedures with a larger margin of safety.

Section snippets

Setting

The University Medical Center Utrecht (UMCU) is a 1042-bed, tertiary academic center in The Netherlands performing 300 ERCP procedures yearly. At the time of the detection of the outbreak (July 2015), 2 Olympus TJF-Q180V (Zoeterwoude, The Netherlands) duodenoscopes (A and B) and 2 older Olympus TJF-160VR models (C and D) were being used. Maintenance and repairs were performed by a single independent service organization (ISO). Duodenoscope A (3.9 years; 571 procedures) had been repaired in May

Outbreak investigation

The outbreak investigation yielded culture results from 81 patients of the 102 contact patients. Eight patients refused to participate or did not respond to the request for screening, and 13 patients died in 2015 without any screening or clinical cultures available. An independent committee of medical experts reviewed the medical charts and considered their deaths not to be related to a possible colonization or infection with the outbreak strain. The epidemic curve is shown in Figure 1. In

Discussion

A rising number of reported outbreaks makes us question whether reprocessing of duodenoscopes is adequate enough to prevent infection of patients with exogenous microorganisms. In the outbreak described in this report, during 8 months, 2 duodenoscopes were persistently contaminated with identical MRKP isolates and infected ≥29% of all patients who underwent an ERCP procedure with 1 of the 2 duodenoscopes. In addition to standard outbreak investigations, this investigation included the full

Acknowledgments

We thank the reprocessing staff, medical devices experts, infection control practitioners, medical microbiologists, Bio Information Technology group, and gastroenterologists at the UMCU for their participation and effort in this outbreak investigation. The authors received no specific funding support for the research, authorship, and/or publication of this article.

References (57)

  • K. Visrodia et al.

    Borescope examination: Is there value in visual assessment of endoscope channels?

    Gastrointest Endosc

    (2018)
  • S. Kim et al.

    Risk factors associated with the transmission of carbapenem-resistant Enterobacteriaceae via contaminated duodenoscopes

    Gastrointest Endosc

    (2016)
  • S.F. Alrabaa et al.

    Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment

    Am J Infect Control

    (2013)
  • Z.L. Smith et al.

    Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines

    Gastrointest Endosc

    (2015)
  • C. Bourigault et al.

    Duodenoscopy: an amplifier of cross-transmission during a carbapenemase-producing Enterobacteriaceae outbreak in a gastroenterology pathway

    J Hosp Infect

    (2018)
  • D.H. Lee et al.

    Increasing potential risks of contamination from repetitive use of endoscope

    Am J Infect Control

    (2015)
  • G.G. Ginsberg et al.

    Endoscope repair by original equipment manufacturers and independent service organizations

    Gastrointest Endosc

    (2003)
  • P. Robertson et al.

    Transmission of Salmonella enteritidis after endoscopic retrograde cholangiopancreatography because of inadequate endoscope decontamination

    Am J Infect Control

    (2017)
  • U.S. Senate

    Preventable tragedies: superbugs and how ineffective monitoring of medical device safety fails patients

  • J. Kovaleva et al.

    Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy

    Clin Microbiol Rev

    (2013)
  • J.N. Lin et al.

    Risk of infection following colonoscopy and sigmoidoscopy in symptomatic patients

    Endoscopy

    (2017)
  • P. Wang et al.

    Rates of infection after colonoscopy and osophagogastroduodenoscopy in ambulatory surgery centres in the USA

    Gut

    (2018)
  • Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data 2018 [updated 10-12-2018]

  • P. Decristoforo et al.

    High-quality endoscope reprocessing decreases endoscope contamination

    Clin Microbiol Infect

    (2018)
  • J.J. Brandabur et al.

    Surveillance of guideline practices for duodenoscope and linear echoendoscope reprocessing in a large healthcare system

    Gastrointest Endosc

    (2016)
  • M.J. Alfa et al.

    A survey of reprocessing methods, residual viable bioburden, and soil levels in patient-ready endoscopic retrograde choliangiopancreatography duodenoscopes used in Canadian centers

    Infect Control Hosp Epidemiol

    (2002)
  • P. Saliou et al.

    Measures to improve microbial quality surveillance of gastrointestinal endoscopes

    Endoscopy

    (2016)
  • A.W. Rauwers et al.

    High prevalence rate of digestive tract bacteria in duodenoscopes: a nationwide study

    Gut

    (2018)
  • Cited by (46)

    • Borescope examination and microbial culture results of endoscopes in a tertiary care hospital led to changes in storage protocols to improve patient safety

      2023, American Journal of Infection Control
      Citation Excerpt :

      A large number of steps in the procedure for reprocessing, inadequate training (which leads to missed steps), staffing, and time between procedures can all contribute to inadequate reprocessing.3 Endoscopes that are not reprocessed effectively pose a risk of transmission of pathogens to patients.5,6 Prior studies have demonstrated that internal channel damage in endoscopes has the potential to protect biofilms from high-level disinfection, further increasing the risk of patient-to-patient transmission of pathogens.

    View all citing articles on Scopus

    DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: F. P. Vleggaar: Consultant for and research grant recipient from Boston Scientific. M. J. Bruno: Consultant for 3M, Boston Scientific, and Cook Medical; speaker for Boston Scientific and Cook Medical; grant recipient from 3M, Boston Scientific, Cook Medical, and Pentax Medical. M. C. Vos: Grant recipient from 3M, Pentax Medical, and IMS Innovations. All other authors disclosed no financial relationships relevant to this publication.

    If you would like to chat with an author of this article, you may contact Dr Monkelbaan at [email protected].

    View full text